Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-26

Clinical Trial Update: Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus [EARLY_Phase 1]

View source ↗

Summary

An early-phase study is evaluating extracorporeal photopheresis for Type 1 Diabetes Mellitus; the trial status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Extracorporeal photopheresis (ECP) (extracorporeal photopheresis)

Snippet

Sponsor: Abu Dhabi Stem Cells Center | Conditions: Type 1 Diabetes | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING